Strides Pharma Science Announces Key Changes in Board and Management Leadership
Strides Pharma Science Limited announced changes to its Board of Directors, Key Managerial Personnel (KMP), and Senior Management Personnel (SMP). The changes were approved by the Board of Directors at a meeting held on May 18, 2026, reflecting the company's strategy to strengthen executive management representation and implement its succession planning framework, including the promotion of internal talent.The re-designations and appointments are effective from June 1, 2026, with certain roles ceasing effective May 31, 2026.
Executive Leadership Transitions
The Board approved several key personnel changes:- Venkata Seetharama Raju Pakalapati (Ramaraju PVS): Previously Chief Operating Officer, Mr. Pakalapati is elevated to Board Member and designated as Executive Director of the Company. Consequently, he is identified as Key Managerial Personnel (KMP) effective June 1, 2026. He will cease to hold the role of Senior Management Personnel (SMP) effective May 31, 2026.
- Aditya Arun Kumar: Mr. Kumar, previously Executive Director - Business Development, is redesigned as a Non-Executive Director (Non-Independent) of the Company. He will cease to hold the roles of Executive Director and KMP effective May 31, 2026.
- Nandini Matiyani: Ms. Matiyani is redesigned as the Group CHRO and nominated as Senior Management Personnel (SMP) effective June 1, 2026.
- Ariff Khan: Mr. Khan, previously Executive VP - Manufacturing Operations, is nominated as SMP effective June 1, 2026.
Updated Organizational Structures
Following these changes, the company updated its list of key personnel and operational heads.Board of Directors
The updated list of the Board of Directors effective June 1, 2026, includes:
| Director Name | DIN | Designation |
|---|---|---|
| Arun Kumar | 00084845 | Founder & Non-Executive Director; Chairperson of the Board |
| Dr. Kausalya Santhanam | 06999168 | Independent Director |
| Mukta Arora | 07225715 | Independent Director |
| Homi Rustam Khusrokhan | 00005085 | Independent Director |
| Ameet Hariani | 00087866 | Independent Director |
| Subir Chakraborty | 00130864 | Independent Director |
| Aditya Arun Kumar | 06999081 | Non-Executive Director |
| Badree Komandur | 07803242 | Managing Director & Group CEO |
| Venkata Seetharama Raju Pakalapati (Ramaraju PVS) | 07500141 | Executive Director |
Key Managerial Personnel (KMP)
The updated list of KMP includes:
| Name of KMP | Designation |
|---|---|
| Badree Komandur | Managing Director & Group CEO |
| Venkata Seetharama Raju Pakalapati (Ramaraju PVS) | Executive Director |
| Vikesh Kumar | Group CFO |
| Manjula Ramamurthy | Company Secretary & Compliance Officer |
Senior Management Personnel (SMP)
The updated list of SMP effective June 1, 2026, comprises:
| Name of SMP | Designation |
|---|---|
| Umesh Kale | Chief Quality Officer |
| Dr. Chithambaram Muthulingam | Executive VP - Research & Development |
| Sormistha Ghosh | Group GC, CRO & CSO |
| Nandini Matiyani | Group CHRO |
| Sugeet Chopra | Executive VP - Supply Chain Management |
| Ariff Khan | Executive VP - Manufacturing Operations |
| Amit Gupta | Senior VP - Taxation |
| Vikesh Kumar | Group CFO |
| Manjula Ramamurthy | Company Secretary & Compliance Officer |
STAR Stock Price Movement
As of 3:16 PM, shares of Strides Pharma Science Limited are dropping by 2.27% in live trading, currently trading at ₹1127.5. The stock shed ₹26.20 amid significant volatility, handling a volume of 956,694 shares in the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.